|1.||Caulfield, John P: 2 articles (09/2010 - 02/2009)|
|2.||Doggrell, Sheila A: 1 article (10/2010)|
|3.||Christensen, Anne-Marie: 1 article (10/2010)|
|4.||Navarro, Mercidita T: 1 article (09/2010)|
|5.||Zhang, Xiaoping: 1 article (09/2010)|
|6.||Hisoire, Grace: 1 article (09/2010)|
|7.||Huang, Yue: 1 article (09/2010)|
|8.||Zerbini, C: 1 article (02/2010)|
|9.||Rabbia, M: 1 article (02/2010)|
|10.||Irazoque, F: 1 article (02/2010)|
10/01/2010 - "It is unlikely that pamapimod will be useful in the treatment of rheumatoid arthritis."
10/01/2010 - "The objective of this review was to evaluate the recent clinical trials of pamapimod in subjects with rheumatoid arthritis. "
10/01/2010 - "Pamapimod is a p38α inhibitor being developed for use in the treatment of rheumatoid arthritis. "
10/01/2010 - "There is no clear-cut evidence that pamapimod alone or in the presence of methotrexate is efficacious in subjects with rheumatoid arthritis but it does cause adverse effects. "
10/01/2010 - "Does the p38 MAP kinase inhibitor pamapimod have potential for the treatment of rheumatoid arthritis?"
|2.||Autoimmune Diseases (Autoimmune Disease)
12/01/2008 - "In murine collagen-induced arthritis, pamapimod reduced clinical signs of inflammation and bone loss at 50 mg/kg or greater. "
12/01/2008 - "In a rat model of hyperalgesia, pamapimod increased tolerance to pressure in a dose-dependent manner, suggesting an important role of p38 in pain associated with inflammation. "
|2.||p38 Mitogen-Activated Protein Kinases
|3.||Protein Kinases (Protein Kinase)